National Cancer Institute
Beckett Weldon, our founder's son was selected to be the SYNGAP1 Face of a Rasopathy.
Join a research study at the National Cancer Institute’s Division of Cancer Epidemiology and Genetics. The purpose of the study is to understand what causes RASopathies, and how we can better screen for and treat these
syndromes.
To Learn More About Ongoing Studies, Visit NIH Center for Advancing Translational Sciences.
SYNGAP1-related Disorders
Other Names: Autosomal dominant intellectual disability 5; MRD5; SYNGAP1 syndrome; SYNGAP1-related Disorder; Syngap1 Gene Mutation Linked To Intellectual Disability, Epilepsy, Sensory Processing Disorder, Autism, and Schizophrenia.